Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

2(66.7%)

N/A

1(33.3%)

3Total

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07036536Recruiting

Non-Euploid Embryo Transfer (NEET) Registry

Role: collaborator

NCT06214936Not ApplicableRecruiting

Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield

Role: collaborator

NCT05309694Phase 4Completed

A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

Role: lead

NCT04488211Completed

IVM Survey Among Reproductive Medicine Specialists

Role: collaborator

NCT00094536Phase 4Completed

Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

Role: lead

All 5 trials loaded